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Intestinal permeabilityCeliac disease (CD) is an immune-mediated enteropathy sustained by dietary gluten in susceptible individuals,
and characterized by a complex interplay between adaptive and innate responses against gluten peptides
(PTG). In a recent contribution we have demonstrated that the treatment with PTG induces the expression and
activity of arginase in both murine macrophages and human monocytes from healthy subjects, thus suggesting
a role for arginine and its metabolites in gluten-triggered response of these cells. Here we further explore this
ﬁeld, by addressing the effects of PTG on polyamine synthesis and release in murine RAW264.7 macrophages,
and how they affect epithelial permeability of Caco-2 monolayers. Results obtained show a massive production
and release of putrescine by macrophages upon incubation with gluten peptides; this, in turn, causes a decrease
in TEER in epithelial cells, indicating that PTG-driven secretion of polyamines by macrophages has a role in the
modulation of intestinal permeability in vitro. At a molecular level, putrescine production appears referable to
the activation of C/EBPβ transcription factor, which is known to be responsible for arginase induction in activated
macrophages and is a crucial mediator of inﬂammation. Whether these pathways are stimulated also in vivo
deserves to be further investigated, as well as their role in gluten-driven cellular and intestinal defects typical
of CD patients.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Celiac disease (CD) has been recently deﬁned as “a chronic small
intestinal immune-mediated enteropathy precipitated by exposure to
dietary gluten in genetically predisposed individuals” [1].
Actually, gluten peptides enter the body as components of common
dietary grains, evade destruction by gastrointestinal proteases and
access the lamina propria, where they are deamidated by the enzyme
transglutaminase 2 (also referred to as tissue transglutaminase, tTG)
[2]. Only in patients with CD, however, this deamidation allows for
high-afﬁnity binding to human leucocyte antigen HLA-DQ2 and -DQ8
molecules and subsequently triggers an inﬂammatory reaction, involv-
ing a complex interplay between adaptive and innate responses [3,4].
It is generally accepted, indeed, that CD is a T-cell mediated disease, in
which lamina propria inﬁltrating T lymphocytes release proinﬂamma-
tory cytokines that lead to profound tissue remodeling in response to
gluten ingestion; however, only 2–5% of individuals expressing CD-
associated HLAs develop the disease, indicating that additionalrale, Dipartimento di Scienze
versità degli Studi di Parma, Via
.pathogenetic mechanisms mediated by innate immune activation are
involved [5]. To this concern, recent ﬁndings indicate that, unlike
other food proteins, gluten and its proteolytic fragments, besides induc-
ing a speciﬁc immune response, also activate components of innate
immunity. For example peptides, such as the P31–43 peptide, are not
recognized by T cells but are able to activate an innate immune
response, as well as to damage the celiac intestinal mucosa in vitro
and in vivo [6]. How the activation of immune cells ultimately relates
to in vivo toxicity for celiac patients and, in particular, to the intestinal
affection typical of CD, remains, however, thus far unknown.
During active disease, the architecture of the celiac epithelium is
massively perturbed, with villous ﬂattening and crypt hyperplasia [7],
and the tight junction system appears morphologically altered too [8].
As a result, untreated celiac patients exhibit increased intestinal perme-
ability, which is considered an important contributor to the inﬂux of
gluten peptides into the subepithelial lamina propria [3]. However,
whether altered intestinal permeability is a primary cause or a
consequence of intestinal inﬂammation is still unclear, as well as the
precise mechanisms that control this event.
Several substances are known to be involved in the control of intes-
tinal permeability; among these, a key role has been recently attributed
to polyamines [9]. These organic polycations, namely putrescine,
spermidine and spermine, play a pivotal role in the regulation of many
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translational level [10]. The intracellular content of these molecules is
tightly regulated through processes of both synthesis/degradation and
uptake/release. As far as polyamine transport is concerned, although
the system speciﬁcally involved in this event has not been completely
elucidated thus far, different putative transport models have been
recently proposed, including both endocytosis and active transport
operated bymembrane transporters as those belonging to solute carrier
(SLC) superfamily [11]. When considering polyamine metabolism, on
the other hand, their synthesis is known to involve two alternative
pathways, via ornithine and agmatine, both leading to the formation
of the diamine putrescine, with the other two polyamines deriving
from the subsequent attachment of two propylamine groups to putres-
cine by spermidine and spermine synthetase. However, the role of
agmatine in polyamine metabolism in extra nervous mammalian
tissues is still under debate, although well-characterized in plants,
bacteria, fungi and invertebrates [12]. Therefore, the main factor in
determining tissue polyamine levels remains undoubtedly the activity
of ornithine decarboxylase (ODC), the rate limiting enzyme in poly-
amine synthesis from ornithine [10]. Ornithine, in turn, is produced
from arginine by arginase, which plays a key role in the synthesis of
polyamines under pathological and physiological conditions [13].
The involvement of arginine in the pathogenesis of CD has been thus
far indirectly investigated, with reference to its role as the obliged
precursor of nitric oxide (NO) via the activity of nitric oxide synthase
(NOS) [14]. Several experimental and clinical ﬁndings indicate, indeed,
that high levels of nitrites, stable derivatives of NO, are present in
serum and urine of children with celiac disease and correlate with an
increased expression of iNOS in the small intestine; moreover, NOS
activity appears increased in patients with untreated CD and is partially
corrected by a gluten free diet (GFD) (see [15] for review). Recently, our
group has demonstrated that, besides strengthening the stimulatory
effects of IFNγ on NO production, the treatment with gluten peptides
(PTG) also induces the expression and activity of arginase in both
murine macrophages and human monocytes from healthy subject,
thus suggesting a role for arginine and its metabolites in gluten-
triggered response of these cell models [16]. In the present paper
we further explore thisﬁeld, by addressing the effects of gluten peptides
on polyamines synthesis and release in murine RAW264.7 macro-
phages. The effects of arginine metabolites produced by PTG-treated
macrophage on intestinal epithelial permeability have been also
evaluated.
2. Materials and methods
2.1. Cell cultures and experimental treatments
RAW264.7 murine macrophages and Caco-2 human colon carcino-
ma cells were obtained from the Istituto Zooproﬁlattico Sperimentale
della Lombardia ed Emilia-Romagna (Brescia, Italy) and routinely
cultured in RPMI-1640 medium supplemented with 10% fetal bovine
serum (FBS) and 1%penicillin/streptomycin at 37 °C, pH 7.4, in an atmo-
sphere of 5% CO2.
For the experiments, RAW264.7 cells were seeded onto multi-well
trays (2 × 105 cells/ml) and incubated in complete growth medium in
the absence or in the presence of 10 ng/ml IFNγ, 1 mg/ml gliadin
peptic–tryptic peptides (PTG, obtained as previously described [16])
or both, as indicated. Albumin peptic–tryptic peptides (PTA), obtained
from bovine serum albumin (BSA) through the same enzymatic diges-
tion as PTG (see above), were employed as control. When the inhibition
of ornithine decarboxylase (ODC) was required, cells were pre-treated
for 12 h with 5 mM 2-(diﬂuoromethyl)ornithine (DFMO), before
being incubated in fresh complete growth medium, either in the
absence or in the presence of 1 mg/ml PTG, for further 24 h. For the
experimental treatments under Arg-free conditions, cells were incubat-
ed in a modiﬁed arginine-free RPMI-1640 supplemented with 10% FBS,either in the absence or in the presence of 1 mg/ml PTG for 24 h. At the
end, incubation media were collected and centrifuged for 3 min at
12,000 g, so as to pellet and discard dead cells. The supernatants were,
then, employed as conditioned media (CM) for the treatment of Caco-
2 cultures, or analyzed for nitrite or polyamines content.
Caco-2 cells were seeded on Cell Culture Inserts (12mm in diameter,
pore size 0.4 μm; Falcon) at the density of 3 × 105 cells/ml, with apical
and basolateral ﬂuid volumes of 250 and 700 μl, respectively. Mono-
layers were used after 7 days, when transepithelial electrical resistance
(TEER), measured with EVOM epithelial voltmeter (World Precision
Instruments, Sarasota, FL, USA), reached values N800 Ω/cm2, thus indi-
cating a tightmonolayer. At this time, either the apical or the basolateral
ﬂuids were replaced with Conditioned Medium (CM) from RAW 264.7
cells, while themedium in the other compartment remained unaltered.
TEER was monitored at the indicated times and values expressed as the
percentage of the initial value adjusted for control cell layers according
to the following equation [17]:
ΔTEER %ð Þ ¼ final TEERtreatedfinal TEERcontrol
 initial TEERcontrol
initial TEERtreated
 100:
2.2. NO production
RAW264.7 cells were incubated for 24 h as required by the
experimental plan. At the end, the production of NO was assessed
through the quantiﬁcation of nitrite, stable derivatives of NO, in the
culture media, as already described [18]. A ﬂuorimetric approach was
employed, based on the production of the ﬂuorescent molecule 1-(H)-
naphtotriazole from DAN in the presence of nitrite in an acid environ-
ment. Fluorescence was determined with EnSpire® Multimode Plate
Reader (Perkin Elmer, Monza, Italy). Nitrite production is expressed in
nmol/ml of extracellular medium (μM).
2.3. Determination of citrulline content
The intracellular content of citrulline was determined through HPLC
analysis with a Biochrom 20 Amino Acid Analyzer (Biochrom,
Cambridge, UK) using a High Resolution Column Bio 20 Peek Lithium
and the Physiological Fluid Chemical Kit (Biochrom) for elution, as al-
ready described for arginine [19]. The column efﬂuent was mixed with
ninhydrin reagent, passed through the high temperature reaction coil,
and read by the photometer unit. Data are expressed as nmol/mg of
protein.
2.4. UHPLC-MS/MS analysis of putrescine production
For the determination of putrescine production, cells were seeded
onto 6-well trays and treated as indicated. At the end, extracellular
incubation medium was collected, while cell monolayers were rapidly
washed with ice-cold PBS and the intracellular pool was extracted
through 5 min incubation in EtOH (1 ml/well) at 4 °C. Extracted cells
were ﬁnally dissolved with 0.5% sodium deoxycholate in 1 M NaOH,
so as to determine protein content in each well using a modiﬁed
Lowry procedure [20].
Intra- and extracellular extract samples were analyzed using a
UHPLC (Dionex Ultimate) system equipped with a triple quadrupole
(TSQ Vantage) (Thermo Fisher Scientiﬁc Inc., San Jose, CA, USA). The
RP-C18 column used was an Aeris Peptide, 1.7 μm, 150 mm length
(Phenomenex, Torrance, CA, USA); eluent A was water and 0.2% aceto-
nitrile while eluent B was acetonitrile both acidiﬁed with 0.1% formic
acid. The total ﬂow was maintained at 0.2 ml/min; the gradient started
from 0% of B (0–1.8 min) and it increased at 50% (1.8–13.2 min), this
condition was maintained for 1.8 min (13.2–14 min), then the column
was ﬂashed increasing % of B to 100% (14–14.5 min) for 1.6 min
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in 1.4 min. The total run time was 29.5 min.
The compounds of interest (putrescine, spermine and spermidine)
were monitored using positive ionization mode (spray voltage =
3200 V), with the capillary temperature at 270 °C, while the vaporizer
temperature was kept at 250 °C. The sheath gas ﬂow was 50 units and
the auxiliary gas ﬂow was 15 units. All the other parameters, as S-Lens
RF amplitude value, were obtained by tuning a methanolic standard
solution of the three analytes separately (1000 μg/kg).
The three considered amines were monitored in SRM mode: the
transitions utilized were 89.0 m/z → 72.1 m/z (CE = 10 V) and
89.0 → 55.0 m/z (CE = 20 V) for putrescine, 203.1 m/z → 129. 2 m/z
(CE = 12 V) and 203.1 → 112.1 m/z (CE = 18 V) for spermine and
146.0 m/z → 72.1 m/z (CE = 15 V) and 146.0 → 112.1 m/z (CE =
14 V) for spermidine.
Calibration curve was performed both in ethanol (for intracellular
extracts) and in medium (for extracellular extracts) at the following
concentrations: 2.5, 5, 10, 15 and 20 μM. Chromatographic signals
were integrated using the Xcalibur Software. Amine production is
expressed as nmol/mg of protein for the intracellular content and as
nmol/ml for the extracellular medium (μM).
2.5. Western blot analysis
For the analysis of total C/EBPβ expression, RAW264.7 cells, grown
on 10-diameter Petri dishes (3 × 106 cells/dish) and treated as indicat-
ed, were lysed in RIPA buffer containing a cocktail of protease inhibitors
(Complete, Mini, EDTA-free, Roche). Lysates were, then, sonicated for
5 s and centrifuged at 12,000 g for 10 min at 4 °C. For the subcellular
localization of the transcription factor, nuclear proteins were isolated
by means of Nuclear Extract Kit (Active Motif, Vinci-Biochem, Firenze,
Italy), according to themanufacturer's instructions.Western blot analy-
sis was performed as described previously [21]. Brieﬂy, 20 μg of proteins
were separated by SDS-PAGE (10% acrylamide) and electrophoretically
transferred to PVDF membranes (Immobilon-P membrane, Millipore,
Milano, Italy). Membranes were incubated for 1 h at RT in Tris-
buffered saline solution (TBS; 50 mM Tris–HCl pH 7.5, 150 mM NaCl)
containing 5% dried milk, then incubated overnight at 4 °C in TBS
added with 3% BSA, 1% casein and anti-C/EBPβ (1:200) puriﬁed rabbit
polyclonal antibodies (Santa Cruz Biotechnology, DBA, Milano, Italy).
LAMIN A/C detected with a polyclonal antibody (1:400, Santa Cruz
Biotechnology), or β-tubulin detected with a monoclonal antibody
(1:1000, Santa Cruz Biotechnology) were employed as internal stan-
dard. Immunoreactivity was visualized with enhanced chemilumines-
cence (Millipore, Milano, Italy). The densitometric analysis of blots
was performed employing Image Quant® software by Molecular
Dynamics (GE Healthcare Life Sciences, Milano, Italy).
2.6. qRT-polymerase chain reaction
1 μg of total RNA, extracted with GenElute™Mammalian Total RNA
Miniprep Kit (Sigma-Aldrich) was reverse transcribed and 40 ng of
cDNA were ampliﬁed as described previously [22], employing forward
and reverse primers speciﬁc for cebpb (GGAGACGCAGCACAAGGT and
AGCTGCTTGAACAAGTTCCG), slc3a2/4F2hc (GCAGGACGGTGTGGATGG
and GTCGCTGGTGGATTCAAGTATG) or gapdh (TGTTCCTACCCCCAATGT
GT and GGTCCTCAGTGTAGCCCAAG). The expression of the gene of
interest under each experimental condition was normalized to that of
the housekeeping gene (gapdh) and shown relatively to its expression
level in control, untreated cells (=1).
2.7. Putrescine transport
For the determination of putrescine inﬂux, RAW264.7 cells seeded
on 96-well dishes, were washed with Earle's Balanced Salt Solution
(EBSS) containing (in mM) 117 NaCl, 1.8 CaCl2, 5.3 KCl, 0.9 NaH2PO4,0.8 MgSO4, 5.5 glucose, 26 Tris–HCl adjusted to pH 7.4 or, for sodium-
free determinations, with a modiﬁed EBSS, where NaCl was replaced
with equimolar N-methylglucamine. Cells were then incubated for
30 min in 50 μl of the same solutions containing [1,4-3H(N)]-Putrescine
(19 μM, 2 μCi/ml), both in the absence and in the presence of the indicat-
ed amino acids (2 mM). The experiment was terminated by two rapid
washes (b10 s) in ice-cold urea (300mM) and cellmonolayerswere ex-
tracted in 50 μl ethanol. The radioactivity in cell extracts was quantiﬁed
with a Wallac Microbeta Trilux2 liquid scintillation spectrometer
(Perkin Elmer). Extracted cells were then dissolved with 0.5% sodium
deoxycholate in 1 NNaOH and protein content was determined directly
in each well using a modiﬁed Lowry procedure as previously described
[18]. Putrescine transport is expressed as nmol/mg of protein/min.
When addressing putrescine efﬂux, cells, seeded on 96-well plates,
were loaded with 50 μM [1,4-3H(N)]-putrescine for 15 min in EBSS.
Then, cells were washed twice with EBSS and incubated in 100 μl of
the same solution (efﬂux medium) in the absence or in the presence
of 1 mM putrescine or leucine. At the indicated times efﬂux medium
was removed, replaced with fresh medium and counted for radioactiv-
ity (CPMefﬂux medium) with Wallac Microbeta Trilux2. Cell monolayers
were extracted in 50 μl of ethanol and radioactivity in the extracts was
measured, so as to determine putrescine remained within the cells
(CPMintracellular). The percent of putrescine efﬂux at each time was
calculated according to the formula
CPM efflux medium
CPMintracellular þ CPMtotal efflux media
;%:
2.8. Statistical analysis
Statistical analysis was done with Prism® 5.0 Graph Pad software,
using one-wayANOVA followed by Bonferroni post hoc test. Differences
were considered signiﬁcant when the associated probability value
(p) was b0.05.
The effects of drug combination have been studied by means of
the CompuSyn software (ComboSyn, Inc., available online at www.
combosyn.com), developed by Ting-Chao Chou andNickMartin accord-
ing to the original method of the Combination Index (CI) by Chou and
Talalay [additive (CI = 1); synergistic (CI b 1); antagonistic (CI N 1)]
[23,24].
2.9. Materials
RPMI-1640 and endotoxin-free FBS were purchased from Euroclone
(Milano, Italy). Arg-free RPMI1640 (1X) mod. was from Biochrom AG
and purchased from VWR International PBI s.r.l. (Milano, Italy), as well
as IFNγ. Microtech s.r.l. (Napoli, Italy) provided Falcon plastic dispos-
able. [1,4-3H(N)]-Putrescine (51.8 Ci/mmol) was obtained from
Perkin-Elmer (Monza, Italy). Sigma-Aldrich (Milano, Italy) was the
source of gliadin, albumin, and, unless otherwise speciﬁed, of all the
other chemicals.
3. Results
3.1. Gliadin peptides modify arginine metabolism in macrophages
Previous ﬁndings obtained in our lab sustained the hypothesis of a
role for arginine (Arg) metabolism in the effects exerted by gliadin in
macrophages [16]. To further address this issue, we monitored here
the production of Arg main metabolites in murine macrophages
(RAW264.7 cells) treated for 24 h with gliadin peptides (PTG) or albu-
min peptides (PTA) employed as negative control, both alone or in the
presence of INFγ. Data in Fig. 1 clearly indicate that the treatment
with PTG, but not with PTA, caused a modest, not signiﬁcant increase
of intracellular citrulline content, as well as of nitrites concentration in
AB
Fig. 1. Effects of gliadin peptides on argininemetabolism. RAW264.7 cells were either un-
treated (control) or treatedwith 10 ng/ml IFNγ, 1 mg/ml PTG, 1mg/ml PTA or the indicat-
ed combinations of the compounds in complete growth medium for 24 h. Panel A: The
activity ofNOSwasmonitored through themeasurement of intracellular citrulline content
(empty bars) and the quantization of nitrites in the incubationmedium (solid bars), as de-
scribed in Methods. Panel B: The activation of arginase pathway was monitored by mea-
suring both the intracellular content (empty bars) and the extracellular concentration
(solid bars) of putrescine, as described in Methods . Data are means ± SEM of 4 indepen-
dent determinations. *p b 0.05, **p b 0.01, ***p b 0.001 vs. control, untreated cells;
$$p b 0.01, $$$p b 0.001 vs. PTG-treated cells. n.d.: not detectable.
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tivation of iNOS pathway by gliadin peptides (panel A). When simulta-
neously added to the incubation medium along with INFγ, PTG
stimulated both citrulline and nitrites production in synergism with
the cytokine (CI value b 1, according to the Combination Index method
for drug combination studies described inMethods), due to a further in-
duction of iNOS activity by PTG, beside that due to the cytokine alone
[16]. Under the same experimental conditions, arginase pathway has
been also addressed by monitoring the production of polyamines.
Panel B of Fig. 1 shows that the treatment with gliadin peptides, alone
or in combination with IFNγ, lead to a marked increase in the intracel-
lular content of putrescine and an even more evident accumulation of
this polyamine in the extracellular medium, which could not be
observed upon treatment with PTA. The simultaneous addition of
IFNγ, which per se exerted only a modest increase of the intracellular
level of putrescine, did not further stimulate the PTG-driven release of
the polyamine. No signiﬁcant production of the other polyamines
spermine and spermidine was observed under any of the experimental
conditions adopted (data not shown).
3.2. Gliadin-induced arginase pathway is elicited by C/EBPβ
Since increasing evidences identify C/EBPβ as the transcription
factor essential for arginase 1 (Arg1) expression in macrophages [25,26], we next addressed the involvement of this protein in the PTG-
dependent induction of arginase pathway in RAW 264.7 cells (Fig. 2).
A signiﬁcant modulation of C/EBPβ actually occurred upon stimulation
of RAW264.7 macrophages with PTG, either alone or combined with
INFγ, as indicated by nuclear translocation of the transcription factor
(panels A and B) and by the increased expression of both mRNA and
protein (panels C and D). In particular, an early (1 h), signiﬁcant accu-
mulation of C/EBPβ in the nuclear compartment was evident, along
with a concomitant reduction in the cytosol (panels A and B) in PTG-
treated cells, thus indicating a translocation-mediated activation of the
transcription factor. In parallel, a progressive increase of cebpb mRNA
expression was observed, that reached the maximal values after 8 h
exposure (panel C). At this time, also the expression of C/EBPβ protein
was signiﬁcantly higher in total lysates of PTG-treated than in control,
untreated cells (panel D), hence suggesting that a regulation of the
protein also occurs at transcriptional/translational level.
3.3. Conditioned medium from PTG-treated macrophages affects the
integrity of epithelial monolayer
Due to the evident alteration of Arg metabolism induced by PTG, we
next hypothesized that the release of speciﬁc metabolites by activated
macrophages could somehow have a role in the perturbation of the in-
testinal epithelial integrity, as observed in many clinical events [27]. To
verify this hypothesis, RAW264.7 macrophages were treated for 24 h
with PTG, IFNγ, or both. After this time, culture media were collected
and employed as the incubation medium (Conditioned Medium, CM)
for human intestinal epithelial Caco-2 cells grown on Cell Culture
Inserts. The integrity of the intestinal cell monolayer under the different
experimental conditions was evaluated by monitoring the trans-
epithelial electrical resistance (TEER). As shown in Fig. 3, the addition
of the different CM to the apical compartment of intestinal cultures
did not alter the TEER value of the monolayer (panel A), indicating
that the integrity of the epithelial monolayer was preserved under any
of the experimental conditions adopted. Conversely, when themedium
was added to the basolateral compartment of Caco-2 cultures (panel B),
a progressive, evident decrease in TEER was observed in cells incubated
with conditioned medium from PTG-treated macrophages, both in the
absence (CM-PTG) or in the presence of IFNγ (CM-PTG + IFNγ). The
CM-IFNγ alone, however, was ineffective, and the presence of the cyto-
kine did not further strengthen the effect of the peptide. In a parallel
experiment, the effect of fresh, not-conditioned growth medium con-
taining PTG, IFNγ or both added to the basolateral compartment was
also evaluated (panel C). Since no signiﬁcant change of TEERwas detect-
able under these latter conditions, we can conclude that the alterations
observed in the monostrate permeability of CM-treated Caco-2 mono-
layers are speciﬁcally attributable to the presence in the basolateral
compartment of molecules released by macrophages in CM, and not to
PTG or INFγ themselves.
3.4. Arginine metabolites have a role in the modulation of epithelial barrier
permeability
In light of the results thus far obtained,we next address the potential
link among the production of polyamines by PTG-treated RAW264.7
and the observed impairment of the epithelial integrity of Caco-2 cells.
To this aim, we adopted two experimental strategies able to prevent
the production of polyamines by PTG-treated RAW264.7, i.e. the addi-
tion of 2-(diﬂuoromethyl)ornithine (DFMO), a well-known inhibitor
of the enzyme ornithine decarboxylase (ODC) [28] and the use of an
arginine-free medium, so as to eliminate the substrate required by
ODC. As expected, the levels of extracellular putrescine, which raised
to about 8 μM when RAW264.7 were treated with PTG alone, were
undetectable when PTG was added both along with DFMO or in
arginine-free medium (Fig. 4, panels A and C). These conditioned
media were collected and added to the basolateral compartment of
A B
C D
Fig. 2. Involvement of C/EBPβ in PTG-mediated induction of arginase pathway. RAW264.7 cells were either untreated (control) or treated with 10 ng/ml IFNγ, 1 mg/ml PTG or both in
complete growth medium. The nuclear (panel A) and cytosolic (panel B) localizations of C/EBPβ protein were investigated as described in Methods, after 1 h exposure to the indicated
experimental treatments. The experiments were repeated 3 timeswith comparable results; representative western blots are shown, alongwith the densitometric analyses corresponding
to the means± SEM of the repeats. Panel C: The level of cebpbmRNAwas measured at the indicated times as detailed in Methods. Bars represent means ± SEM of 4 independent deter-
minations, each performed in duplicate. Panel D: The expression of C/EBPβ protein was quantiﬁed in total cell lysates, as described in Methods. A representative western blot is shown,
while the densitometric analysis reported corresponds to the mean ± SEM of 3 independent experiments. *p b 0.05, **p b 0.01, ***p b 0.001 vs. control, untreated cells.
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different times as an indicator of epithelial integrity. As shown, neither
DFMO (panel C) nor arginine-free medium (panel D) did affect TEER0 12 24 36 48
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Fig. 4. Role of arginine metabolites in the modulation of the epithelial permeability of
Caco-2 monolayers. Panels A and C: RAW264.7 cells were either untreated or treated
with 1 mg/ml PTG in complete growth medium in the absence or in the presence of
5 mM DFMO (panel A) or in arginine-free medium (panel C), as indicated. After 24 h,
the extracellular concentration of putrescine under each condition was measured as de-
scribed inMethods. Data aremeans± SEM of 4 independent determinations. n.d.: not de-
tectable. Panels B and D: Following exposure to the treatments above, the conditioned
media (CM) from RAW264.7 cells were collected and added to the basolateral compart-
ment of Caco-2 intestinal epithelial cell cultures. CM obtained as described in panels A
and C were used for the determinations shown in panels B and D, respectively.
Transepithelial electrical resistance (TEER) was measured at the indicated times, as de-
scribed in Methods. Data are means ± SEM of 4 independent determinations.
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the hypothesis that the release of putrescine by PTG-treated macro-
phages is somehow involved in the increase of epithelial permeability.
Actually, after 48 h of incubation, TEER decrease in CM-PTG treated
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Fig. 5. 4F2hc expression and putrescine transport in RAW264.7 macrophages. Panel A: RAW26
mRNAwas extracted and the expression of 4F2hcmeasured as described inMethods. Data arem
assessed as described in Methods with 30-min incubation in EBSS supplemented with [1,4-3H(
(2 mM) of putrescine (+Put), arginine (+Arg) or leucine (+Leu), or in a sodium-free EBSS (−
plicate. Panel C: For the measurement of putrescine efﬂux, cells were maintained for 15 min in
EBSS, in the absence (control) or in the presence of 1mMputrescine (+Put) or leucine (+Leu).
means ± SEM of 3 independent experiments, each performed in triplicate. **p b 0.01, ***p b 0considering the absence of arginine, the protective effect was more ev-
ident for short-term incubations (2, 4 and 6h),when TEER decreasewas
almost negligible. Anyway, even after 48 h in CM-Arg free + PTG, TEER
decrease was reduced by more than 30% with respect to cells main-
tained in CM-PTG.
3.5. 4F2hc is induced by PTG in RAW264.7 macrophages
The system for the transmembrane transport of polyamines inmam-
malian cells has not been fully deﬁned, yet. However, increasing
evidences suggest that some of the known membrane transporters
might be involved in polyamines ﬂuxes [11]. Among these, SLC3A2/
4F2hc has been identiﬁed as a component of the DiAmine eXporter
(DAX) which exports putrescine in CHO cells [29]. In light of these evi-
dences, we addressed here the expression of slc3a2/4F2hc in RAW264.7
macrophages. As shown in Fig. 5, panel A, a signiﬁcant induction of
slc3a2/4F2hcmRNAoccurred upon treatmentwith PTG, thus suggesting
an involvement of this transport component in mediating putrescine
efﬂux under our experimental conditions. In an effort to identify the
transport system speciﬁcally engaged in this process, the transmem-
brane transport of 3H-putrescine in RAW264.7 cells has beenmeasured
under conditions able to discriminate the contribution of the different
transporters whose operation requires 4F2hc as heavy chain (panel B).
In particular, the reduction of putrescine inﬂux by an excess of the sub-
strate conﬁrmed the contribution of a saturable transport system.
Moreover, since the absence of sodium signiﬁcantly lowered putrescine
ﬂuxes with respect to what observed in its presence (control), we
can conclude that the transporter involved operates in a sodium-
dependent manner (thus excluding the contribution of system L and
system x−c). However, neither an excess of extracellular arginine nor
of leucine did affect putrescine uptake, hence excluding the involve-
ment of 4F2hc-linked co-transporter system y+L. This result has been
also conﬁrmed by measuring the efﬂux of the polyamine. As shown in
panel C, indeed, the presence of leucine in the extracellular medium
did not trans-stimulate putrescine efﬂux, as it would have been expect-
ed for system y+L; the efﬂux was neither affected by extracellular
putrescine itself.
4. Discussion
In celiac disease (CD) an evident increase of mucosal permeability is
observed since the early phases of the pathological onset, and associates
with the small-intestinal inﬂammation and damaged morphology [30,
31]. However, the precise mechanisms that lead to compromised intes-
tinal barrier function in CD are still under debate, although a key role+L
eu
-
Na
**
0 2 4 60
5
10
15
20 control
+Put
+Leu
time, min
Pu
tre
sc
in
e 
ef
flu
x
(%
 
of
 
pr
ea
cc
um
ul
at
ed
)
C
4.7 cells were either untreated (control) or treated for 24 h with 1 mg/ml PTG. At the end,
eans± SEMof 3 experiments, each performed in duplicate. Panel B: Putrescine uptakewas
N)]-putrescine (19 μM, 2 μCi/ml) in the absence (control) or in the presence of an excess
Na+), as indicated. Data are means ± SEM of 3 experiments, each performed in quadru-
EBSS containing 50 μM [1,4-3H(N)]-putrescine, rapidly washed, then incubated in 100 μl
At the indicated times, putrescine efﬂuxwas determined as described inMethods. Data are
.001 vs. control, untreated cells.
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complexes in the intestinal epithelial layer [32].
Actually, the maintenance of gastrointestinal epithelial homeostasis
aswell as of its selective barrier function depend on a complex interplay
of processes involving intestinal epithelial cell proliferation, differentia-
tion, migration, and apoptosis, but also protein–protein networks that
mechanically link adjacent cells and seal the intercellular space, includ-
ing tight junctions (TJs), adherens junctions, desmosomes, and gap
junctions [33]. Multiple factors are known to modulate epithelial
permeability in in vitro and in vivomodels of intestinal barrier; among
the others, polyamines are gaining peculiar relevance in the ﬁeld of
intestinal disorders, due to the multiple roles they hold in the mainte-
nance of epithelial functions [9,34]. Accordingly, in the present paper
we provide evidence for the involvement of these molecules also in
the modiﬁcation of intestinal epithelial integrity driven by gliadin-
activated macrophages in vitro. In a previous contribution, we reported,
indeed, that gliadin peptides (PTG) induce the stimulation of arginase
pathway in both murine macrophages and human monocytes [16].
Here, we further address this issue, demonstrating that this event
ultimately leads to a massive production of polyamines by RAW264.7
macrophages (see Fig. 1), that are released in the extracellularmedium.
The use of PTG as an in vitromodel of gluten digests is still a matter of
debate, since some of the effects described in literature are likely due
to peptic tryptic digests, rather than to gluten itself [35]. In our hands,
however, the lack of stimulation of arginine metabolism by albumin
peptides (PTA), obtained with the same enzymatic digestion as PTG
(see Fig. 1), conﬁrms the speciﬁc role of gluten peptides, and rules out
the possibility that pepsin-tryptic aspeciﬁc digests are responsible for
the effects observed in PTG treated macrophages.
Gliadin-driven release of putrescine, in turn, affects epithelial integ-
rity: the incubation of intestinal epithelialmonolayerswith conditioned
mediumobtained fromPTG-, but not IFNγ-treatedmacrophages causes,
indeed, a signiﬁcant impairment of epithelial permeability, as indicated
by the decrease in TEER in Caco-2 epithelial monolayers, which is not
further modiﬁed by the presence of the cytokine (see Fig. 3). Since
TEER decrease is efﬁciently prevented by the inhibition of polyamines
biosynthetic pathway in PTG-treated macrophages (see Fig. 4), we can
deﬁnitely refer the alteration of epithelial monolayer permeability to
the production of putrescine consequent to the interaction of macro-
phages with gluten peptides and to the release of this polyamine in
the extracellular milieu. The incubation of polarized Caco-2 cultures in
fresh growth medium containing PTG, both alone or combined with
IFNγ, lead to an almost negligible decrease of TEER (see Fig. 3, panel
C). Although these results are apparently in contrast with other contri-
butions addressing the same issue (see [36–39] for examples), it must
be underlined that our results have been obtained by incubating intes-
tinal monolayers at the basolateral, rather than at the apical side, likely
accounting for the discrepancies observed. Although the mechanisms
responsible for polyamines transport have been thus far only roughly
deﬁned, evidences indicate that both endocytosis and solute carrier
transporters are involved in their uptake in the gastrointestinal tract
[40]. In particular, NOproduction is known to be required for the release
of polyamines from intracellular vesicles [41], while a DiAmine eXporter
(DAX) containing SLC3A2 has been identiﬁed and proposed to mediate
putrescine efﬂux in colon epithelial cells [29]. Interestingly, we show
here that both the pathway of NO (see Fig. 1) and the expression of
SLC3A2/4F2hc (see Fig. 5) are induced in RAW264.7 macrophages by
the incubation with gliadin peptides, hence suggesting that both
processes could be involved in polyamines release under our experi-
mental conditions.
As previously reported, polyamines contribution to gut homeostasis
is well documented [9]. However, their role in the intestinal compart-
ment is thus far not deﬁnitely understood, due to their ambivalent
effects: their depletion is, indeed, known to increase epithelial
paracellular permeability partially by repressing the expression of TJ
proteins Zona Occludens-1 (ZO-1), occludin and E-cadherin [42–44];on the other hand, it has been also demonstrated that the accumulation
of polyamines within intestinal cell lines promotes their apoptosis
through multiple signaling pathways, hence affecting intestinal integri-
ty [9,45]. In our contribution, themolecularmechanisms responsible for
the observed reduction of epithelial integrity by PTG-treated macro-
phages were not addressed; hence, nor an alteration of tight junctions
nor the eventual induction of epithelial cell death by polyamines can
be thus far excluded and will be object of further analyses.
The massive production of polyamines observed in murine macro-
phages upon incubation with gliadin peptides associates with the
induction of C/EBPβ (see Fig. 2), the transcription factor speciﬁcally
responsible for toll-like receptor (TLR) mediated induction of arginase
in macrophages [46]. Similarly, a comparable PTG-driven induction of
the transcription factor has been obtained in humanmonocytes isolated
from peripheral blood samples of healthy donors, alongwith a concom-
itant induction of IL-1βmRNA expression (Barilli et al., unpublished re-
sults). These results are consistent with literature ﬁndings stating that
C/EBPβ is involved inmyeloid development andmacrophage activation
[25,47], and is a crucial mediator of inﬂammation in activated macro-
phages [48], particularly responsible for IL-1β transcription [49]. Our
hypothesis is, hence, that this protein could be involved both in the
gliadin-dependent activation of arginase pathway in macrophages
[16] and, at least in part, in the onset of the inﬂammatory dysfunction
described upon interaction of immune cells with gliadin [50]. Whether
this transcription factor can be actually activated in macrophages
in vivo by the presence of gluten deserves to be elucidated.
Altogether our results add to the plethora of cellular pathways acti-
vated by gliadin and its undigested peptides not only in cells and the
intestinal mucosa of patients with CD, but also in normal subjects or in
different diseases [6]. We can speculate that these pathways, constitu-
tively altered in celiac cells, render CD patients more susceptible than
healthy subjects to the effects of gluten, ultimately producing, once in
the celiac background, the well-known clinical feature of the disease;
however, further investigations addressing this issue are required to
shade light on the role of these pathways in gluten driven cellular and
intestinal defects typical of CD patients.Conﬂicts of interest
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